Evidence for the formation of amphotericin B-phospholipid complexes in Langmuir monolayers (Q71616221)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8842037%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Evidence for the formation of amphotericin B-phospholipid complexes in Langmuir monolayers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8842037%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

M R Lance

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8842037%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

C Washington

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8842037%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

S S Davis

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8842037%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 July 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8842037%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

published in

Pharmaceutical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8842037%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8842037%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8842037%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

1008-1014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8842037%20AND%20SRC:MED&resulttype=core&format=json

Influence of phospholipid/amphotericin B ratio and phospholipid type on in vitro renal cell toxicities and fungicidal activities of lipid-associated amphotericin B formulations

20 October 2019

cites work

1 reference

12 December 2020

Nephrotoxicity of amphotericin B.

1 reference

12 December 2020

Periodic structures in lipid monolayer phase transitions

1 reference

12 December 2020

Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B.

1 reference

12 December 2020

Submicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterization

1 reference

12 December 2020

Supported phospholipid bilayers

1 reference

12 December 2020

Clinical use of amphotericin B and derivatives: lore, mystique, and fact

1 reference

12 December 2020

Structure and toxicity of amphotericin B/triglyceride emulsion formulations

1 reference

12 December 2020

Toxicity of solubilized and colloidal amphotericin B formulations to human erythrocytes

1 reference

12 December 2020

In-vivo studies of amphotericin B liposomes derived from proliposomes: effect of formulation on toxicity and tissue disposition of the drug in mice

1 reference

12 December 2020

Amphotericin B: 30 years of clinical experience

1 reference

12 December 2020

Mechanism of the selective toxicity of amphotericin B incorporated into liposomes.

1 reference

12 December 2020

Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes

1 reference

12 December 2020

Translational diffusion in phospholipid monolayers measured by fluorescence microphotolysis

1 reference

12 December 2020

Toxicity of amphotericin B emulsion to cultured canine kidney cell monolayers

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1016046321726

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8842037%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference